Molecular typing is predicated on molecular genetic screening and is not yet routinely obtainable. Molecular subtypes and immunohistochemical surrogate markers of the tumors (HR, HER2, triple detrimental) correlate in about 70%. The differentiation of luminal A and B subtypes by HR position and proliferation markers like Ki-sixty seven could https://leonardz096cnx7.fliplife-wiki.com/user